Peter Whelan

3.6k total citations
87 papers, 2.5k citations indexed

About

Peter Whelan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Peter Whelan has authored 87 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 27 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Peter Whelan's work include Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (33 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Peter Whelan is often cited by papers focused on Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (33 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Peter Whelan collaborates with scholars based in United Kingdom, Netherlands and Belgium. Peter Whelan's co-authors include J. P. BRITTON, Anthony Dowell, Laurence Collette, Aldo Bono, D.W.W. Newling, L. Denis, R. Sylvester, Jandeilson L. Moura, Muriel Debois and J Casselman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Peter Whelan

87 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Whelan United Kingdom 25 1.5k 650 468 458 355 87 2.5k
A. Akdaş Türkiye 19 1.8k 1.2× 487 0.7× 339 0.7× 507 1.1× 299 0.8× 102 2.7k
Ubirajara Ferreira Brazil 22 1.8k 1.2× 602 0.9× 362 0.8× 345 0.8× 399 1.1× 132 2.6k
Fritz H. Schroeder Netherlands 29 1.4k 1.0× 446 0.7× 352 0.8× 334 0.7× 522 1.5× 63 2.4k
Shigeto Ishidoya Japan 25 796 0.5× 752 1.2× 515 1.1× 192 0.4× 413 1.2× 111 2.2k
Francesco Paolo Selvaggi Italy 27 1.0k 0.7× 589 0.9× 240 0.5× 259 0.6× 625 1.8× 83 2.5k
M. Pavone‐Macaluso Italy 24 1.2k 0.8× 1.3k 2.1× 284 0.6× 413 0.9× 423 1.2× 140 2.9k
Anton J. Bueschen United States 19 1.1k 0.8× 293 0.5× 202 0.4× 302 0.7× 291 0.8× 49 1.8k
Anthony L. Patterson United States 23 1.2k 0.9× 333 0.5× 333 0.7× 213 0.5× 530 1.5× 44 1.6k
Robert R. Bahnson United States 27 1.1k 0.8× 696 1.1× 120 0.3× 385 0.8× 407 1.1× 96 2.5k
Shinichi Yamashita Japan 26 968 0.7× 512 0.8× 156 0.3× 411 0.9× 719 2.0× 154 2.2k

Countries citing papers authored by Peter Whelan

Since Specialization
Citations

This map shows the geographic impact of Peter Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Whelan more than expected).

Fields of papers citing papers by Peter Whelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Whelan. The network helps show where Peter Whelan may publish in the future.

Co-authorship network of co-authors of Peter Whelan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Whelan. A scholar is included among the top collaborators of Peter Whelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Whelan. Peter Whelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Whelan, Peter, et al.. (2010). EBU Announces the Curriculum for Urologic Training in Europe. European Urology. 59(3). 370–371. 6 indexed citations
3.
Bono, Aldo, Peter Whelan, Maurizio Brausi, et al.. (2009). Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group. European Urology. 55(6). 1269–1277. 170 indexed citations
4.
Kotwal, Sanjeev, et al.. (2007). Unusual squamous cell carcinoma of the scrotum arising from a well healed, innocuous scar of an infertility procedure: a case report. Annals of The Royal College of Surgeons of England. 89(5). 17–19. 4 indexed citations
5.
Kotwal, Sanjeev, Ananya Choudhury, C.F. Johnston, et al.. (2007). Similar Treatment Outcomes for Radical Cystectomy and Radical Radiotherapy in Invasive Bladder Cancer Treated at a United Kingdom Specialist Treatment Center. International Journal of Radiation Oncology*Biology*Physics. 70(2). 456–463. 99 indexed citations
6.
7.
Sternberg, Cora N., Peter Whelan, John Hetherington, et al.. (2005). Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer. Oncology. 68(1). 2–9. 167 indexed citations
8.
Berridge, David, et al.. (2004). Penile Ulcer: An Unusual Presentation of Cholesterol Emboli. European Journal of Vascular and Endovascular Surgery. 27(4). 447–448. 2 indexed citations
9.
Kil, Paul J.M., Urs E. Studer, Peter Whelan, et al.. (2002). Tissue Polypeptide-Specific Antigen (TPS) Determinations before and during Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostatic Carcinoma. European Urology. 43(1). 31–38. 6 indexed citations
10.
Whelan, Peter, Gareth Griffiths, Michael J. Stower, et al.. (2001). Preliminary results of a MRC randomised controlled trial of post-operative irrigation of superficial bladder cancer. UCL Discovery (University College London). 11 indexed citations
11.
Protheroe, Andrew, Rosamonde E. Banks, Jennifer Southgate, et al.. (1999). Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer. British Journal of Cancer. 80(1-2). 273–278. 30 indexed citations
13.
Reijke, Theo M. de, F. Keuppens, Peter Whelan, et al.. (1999). ORCHIECTOMY AND ORCHIECTOMY PLUS MITOMYCIN C FOR METASTATIC PROSTATE CANCER IN PATIENTS WITH POOR PROGNOSIS:. The Journal of Urology. 1658–1658. 5 indexed citations
14.
Denis, L., Jandeilson L. Moura, Aldo Bono, et al.. (1993). Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853). Urology. 42(2). 119–130. 209 indexed citations
15.
Simpson, Karen H, P. J. Murphy, P. V. Colthup, & Peter Whelan. (1992). Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacology. 109(4). 497–498. 50 indexed citations
16.
CUMMING, J. A., D. Kirk, D.W.W. Newling, T. B. Hargreave, & Peter Whelan. (1990). A Multi-Centre Phase Two Study of Intravesical Epirubicin in theTreatment of Superficial Bladder Tumour. European Urology. 17(1). 20–22. 11 indexed citations
17.
Kelleher, J., et al.. (1990). Interactions of retinoic acid and androgens in human prostatic tissue. The Prostate. 16(4). 299–304. 16 indexed citations
18.
BRITTON, J. P., Anthony Dowell, & Peter Whelan. (1989). Dipstick haematuria and bladder cancer in men over 60: results of a community study.. BMJ. 299(6706). 1010–1012. 92 indexed citations
19.
Kelleher, J., et al.. (1987). Cytosolic retinoic acid‐binding protein in human prostatic dysplasia and neoplasia. The Prostate. 11(2). 127–132. 11 indexed citations
20.
King, Hollis H. & Peter Whelan. (1984). Treatment of acute scrotal pain.. BMJ. 288(6430). 1576.2–1577. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026